Trial Profile
An open-label, randomized, multicenter trial to evaluate continuation rates, side effects and acceptability of NuvaRing [ethinyl estradiol/etonogestrel] versus OrthoEvra [ethinyl estradiol/norelgestromin]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Aug 2018
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/etonogestrel (Primary) ; Ethinylestradiol/norelgestromin (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms PARIS
- 24 Nov 2006 New trial record.